MAGA’s favorite psychedelic
The Trump administration is pursuing the legalization of ibogaine, a psychedelic drug that may help treat opioid addiction and PTSD. President Trump recently signed an executive order to expedite the FDA's review process for ibogaine, responding to lobbying from veterans' groups. Podcaster Joe Rogan has played a role in promoting the drug's potential benefits, even attending the executive order signing in the White House.
- ▪Ibogaine is currently classified as a Schedule I drug, making it illegal at the federal level.
- ▪The drug has shown promise in treating opioid addiction and PTSD, attracting attention from the Trump administration.
- ▪Veterans' groups have been advocating for ibogaine as a treatment option, leading to the recent executive order for faster FDA review.
Opening excerpt (first ~120 words) tap to expand
PodcastsMAGA’s favorite psychedelicIs Joe Rogan making federal drug policy?by Kelli Wessinger and Jonquilyn HillMay 19, 2026, 7:15 PM UTCShareGiftHealth Secretary Robert F. Kennedy Jr. and podcaster Joe Rogan look on as President Donald Trump shakes hands with W. Bryan Hubbard, CEO of Americans for Ibogaine, during an executive order signing ceremony in the Oval Office on April 18, 2026. Jim Watson/AFP via Getty ImagesThe Trump administration has a surprising new agenda item: It’s all-in on legalizing a psychedelic drug called ibogaine.Ibogaine is classified as a Schedule I drug, which means it’s illegal on the federal level.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Vox.
Discussion
0 commentsMore from Vox
